JP2024507324A5 - - Google Patents

Info

Publication number
JP2024507324A5
JP2024507324A5 JP2023544229A JP2023544229A JP2024507324A5 JP 2024507324 A5 JP2024507324 A5 JP 2024507324A5 JP 2023544229 A JP2023544229 A JP 2023544229A JP 2023544229 A JP2023544229 A JP 2023544229A JP 2024507324 A5 JP2024507324 A5 JP 2024507324A5
Authority
JP
Japan
Application number
JP2023544229A
Other languages
Japanese (ja)
Other versions
JP2024507324A (ja
JPWO2022165204A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/014349 external-priority patent/WO2022165204A1/en
Publication of JP2024507324A publication Critical patent/JP2024507324A/ja
Publication of JPWO2022165204A5 publication Critical patent/JPWO2022165204A5/ja
Publication of JP2024507324A5 publication Critical patent/JP2024507324A5/ja
Pending legal-status Critical Current

Links

JP2023544229A 2021-01-28 2022-01-28 移植片対宿主病の治療のための組成物および方法 Pending JP2024507324A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163142905P 2021-01-28 2021-01-28
US63/142,905 2021-01-28
US202163248074P 2021-09-24 2021-09-24
US63/248,074 2021-09-24
PCT/US2022/014349 WO2022165204A1 (en) 2021-01-28 2022-01-28 Compositions and methods for the treatment of graft versus host disease

Publications (3)

Publication Number Publication Date
JP2024507324A JP2024507324A (ja) 2024-02-19
JPWO2022165204A5 JPWO2022165204A5 (https=) 2025-02-05
JP2024507324A5 true JP2024507324A5 (https=) 2025-02-05

Family

ID=80461100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023544229A Pending JP2024507324A (ja) 2021-01-28 2022-01-28 移植片対宿主病の治療のための組成物および方法

Country Status (11)

Country Link
US (3) US20220233645A1 (https=)
EP (2) EP4635509A1 (https=)
JP (1) JP2024507324A (https=)
KR (1) KR20230167019A (https=)
AU (1) AU2022212119A1 (https=)
BR (1) BR112023014978A2 (https=)
CA (1) CA3206093A1 (https=)
ES (1) ES3044110T3 (https=)
IL (1) IL304675A (https=)
MX (1) MX2023008793A (https=)
WO (1) WO2022165204A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025208047A1 (en) * 2024-03-28 2025-10-02 Vectivbio Ag Glucagon-like peptide 2 (glp-2) analogs for the treatment of graft versus host disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8421271B2 (en) * 2009-08-31 2013-04-16 General Electric Company Apparatus for transferring energy using onboard power electronics and method of manufacturing same
EP2314616A1 (en) 2009-10-23 2011-04-27 Ferring B.V. Peptidic GLP-2 agonists
EP3924369A1 (en) * 2019-02-11 2021-12-22 OPKO Biologics Ltd. Long-acting glp-2 analogs
KR20230038187A (ko) 2020-06-09 2023-03-17 벡티브바이오 에이지 아프라글루타이드의 제조, 제형화 및 투여

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
JP2024507324A5 (https=)
CL2025003705S1 (es) Rampa para maniobras vehiculares.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307047644S (https=)
BY13142U (https=)
BY13135U (https=)
BY13137U (https=)
BY13176U (https=)
BY13140U (https=)
CN307049896S (https=)
BY13152U (https=)
CN307049471S (https=)
CN307048221S (https=)
BY23966C1 (https=)